Cubist Systematic Strategies’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$85.7K Sell
63,484
-94,720
-60% -$107K ﹤0.01% 2793
2025
Q2
$150K Buy
158,204
+144,407
+1,047% +$93.6K ﹤0.01% 2654
2025
Q1
$6.36K Buy
+13,797
New +$8.71K ﹤0.01% 2769
2024
Q2
Sell
-1,404,928
Closed -$3.37M 3734
2024
Q1
$3.37M Buy
+1,404,928
New +$3.02M 0.04% 1239
2023
Q3
Sell
-179,327
Closed -$411K 3752
2023
Q2
$411K Buy
179,327
+173,405
+2,928% +$460K ﹤0.01% 2503
2023
Q1
$14.4K Sell
5,922
-12,323
-68% -$28.2K ﹤0.01% 3695
2022
Q4
$34.8K Sell
18,245
-4,600
-20% -$9.79K ﹤0.01% 3946
2022
Q3
$55K Buy
+22,845
New +$63.2K ﹤0.01% 4114
2022
Q2
Sell
-10,816
Closed -$23K 4461
2022
Q1
$23K Sell
10,816
-55,992
-84% -$155K ﹤0.01% 3469
2021
Q4
$263K Buy
66,808
+22,204
+50% +$108K ﹤0.01% 2891
2021
Q3
$215K Buy
+44,604
New +$183K ﹤0.01% 2548
2021
Q2
Sell
-12,943
Closed -$76K 3013
2021
Q1
$76K Sell
12,943
-32,104
-71% -$222K ﹤0.01% 2689
2020
Q4
$154K Buy
+45,047
New +$85.9K ﹤0.01% 2331
2019
Q4
Sell
-42,879
Closed -$129K 2493
2019
Q3
$129K Buy
+42,879
New +$133K ﹤0.01% 1885
2019
Q2
Sell
-20,828
Closed -$116K 2528
2019
Q1
$116K Buy
20,828
+10,156
+95% +$61.7K ﹤0.01% 1960
2018
Q4
$71K Sell
10,672
-6,700
-39% -$54.3K ﹤0.01% 1816
2018
Q3
$185K Sell
17,372
-11,033
-39% -$126K 0.01% 1436
2018
Q2
$341K Buy
28,405
+2,373
+9% +$24.3K 0.02% 1003
2018
Q1
$223K Buy
26,032
+4,569
+21% +$42.3K 0.01% 1335
2017
Q4
$212K Buy
21,463
+9,321
+77% +$96.8K 0.01% 1494
2017
Q3
$149K Buy
+12,142
New +$179K 0.01% 1543
2017
Q2
Sell
-14,055
Closed -$202K 1796
2017
Q1
$202K Buy
+14,055
New +$209K 0.01% 1178
2016
Q4
Sell
-17,292
Closed -$312K 1813
2016
Q3
$312K Buy
+17,292
New +$278K 0.02% 990
2015
Q3
Sell
-13,814
Closed -$111K 1940
2015
Q2
$111K Sell
13,814
-286
-2% -$2.1K 0.01% 1605
2015
Q1
$93K Sell
14,100
-14,643
-51% -$100K ﹤0.01% 1679
2014
Q4
$183K Buy
+28,743
New +$232K 0.01% 1546

Other funds holding LXRX